Frederick L. Ruberg

15.5k total citations · 7 hit papers
123 papers, 7.3k citations indexed

About

Frederick L. Ruberg is a scholar working on Molecular Biology, Nephrology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Frederick L. Ruberg has authored 123 papers receiving a total of 7.3k indexed citations (citations by other indexed papers that have themselves been cited), including 92 papers in Molecular Biology, 48 papers in Nephrology and 31 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Frederick L. Ruberg's work include Amyloidosis: Diagnosis, Treatment, Outcomes (91 papers), Parathyroid Disorders and Treatments (47 papers) and Eosinophilic Disorders and Syndromes (17 papers). Frederick L. Ruberg is often cited by papers focused on Amyloidosis: Diagnosis, Treatment, Outcomes (91 papers), Parathyroid Disorders and Treatments (47 papers) and Eosinophilic Disorders and Syndromes (17 papers). Frederick L. Ruberg collaborates with scholars based in United States, United Kingdom and Italy. Frederick L. Ruberg's co-authors include John L. Berk, Mathew S. Maurer, Martha Grogan, Mazen Hanna, Omar K. Siddiqi, Jeffery W. Kelly, Matthew J. Maurer, Vaishali Sanchorawala, Caroline S. Fox and Ramachandran S. Vasan and has published in prestigious journals such as JAMA, Circulation and Journal of Clinical Investigation.

In The Last Decade

Frederick L. Ruberg

118 papers receiving 7.1k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Pericardial Fat, Visceral Abdominal Fat, Cardiovascular Disease Risk Factors, and Vascular Calcification in a Community-Based Sample

2008 831 citations Frederick L. Ruberg et al. Circulation profile →
Transthyretin Amyloid Cardiomyopathy

2019 633 citations Frederick L. Ruberg, Martha Grogan et al. Journal of the American College of Cardiology profile →
Transthyretin (TTR) Cardiac Amyloidosis

2012 474 citations Frederick L. Ruberg, John L. Berk Circulation profile →
Cardiac Amyloidosis: Evolving Diagnosis and Management: A Scientific Statement From the American Heart Association

2020 419 citations Mathew S. Maurer, Amrut V. Ambardekar et al. Circulation profile →
Expert Consensus Recommendations for the Suspicion and Diagnosis of Transthyretin Cardiac Amyloidosis

2019 331 citations Mathew S. Maurer, Sharmila Dorbala et al. profile →
2023 ACC Expert Consensus Decision Pathway on Comprehensive Multidisciplinary Care for the Patient With Cardiac Amyloidosis

2023 215 citations Frederick L. Ruberg, Amrut V. Ambardekar et al. Journal of the American College of Cardiology profile →
Cardiac Amyloidosis Due to Transthyretin Protein

2024 65 citations Frederick L. Ruberg, Matthew J. Maurer JAMA profile →

Peers

Countries citing papers authored by Frederick L. Ruberg

Since Specialization

Citations

This map shows the geographic impact of Frederick L. Ruberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frederick L. Ruberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frederick L. Ruberg more than expected).

Fields of papers citing papers by Frederick L. Ruberg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frederick L. Ruberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frederick L. Ruberg. The network helps show where Frederick L. Ruberg may publish in the future.

Co-authorship network of co-authors of Frederick L. Ruberg

This figure shows the co-authorship network connecting the top 25 collaborators of Frederick L. Ruberg. A scholar is included among the top collaborators of Frederick L. Ruberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frederick L. Ruberg. Frederick L. Ruberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Changes in Myocardial Light Chain Amyloid Burden After Plasma Cell Therapy 2025 ·JACC. Cardiovascular imaging ·Dominik C. Benz, Olivier Clerc, Sarah Cuddy, Vasvi Singh, Marie Foley Kijewski, Giada Bianchi, Andrew J. Yee, Frederick L. Ruberg, Michael Jerosch‐Herold, Raymond Y. Kwong, Marcelo F. Di Carli, Ronglih Liao, Rodney H. Falk, Sharmila Dorbala	0
2	Abnormal global longitudinal strain and reduced serum inflammatory markers in cardiac AL amyloidosis patients without significant amyloid fibril deposition 2025 ·Amyloid ·(unknown), (unknown), (unknown), (unknown), Pushpinder Bawa, Feiya Wang, Elena S. Klimtchuk, (unknown), Gareth J. Morgan, Tatiana Prokaeva, Andrew Staron, Frederick L. Ruberg, Vaishali Sanchorawala, (unknown), George J. Murphy	0
3	The Last Decade in Cardiac Amyloidosis 2025 ·JACC. Cardiovascular imaging ·(unknown), Adam Ioannou, Sarah Cuddy, Sharmila Dorbala, Ahmad Masri, James Moon, Vasvi Singh, Olivier Clerc, Michael G. Hanna, Frederick L. Ruberg, (unknown), Michele Emdin, Julian D. Gillmore	11
4	Transthyretin Cardiac Amyloidosis Evaluation and Management: 2025 ACC Concise Clinical Guidance 2025 ·Journal of the American College of Cardiology ·(unknown), Amrut V. Ambardekar, Richard K. Cheng, Jan M. Griffin, Matthew J. Maurer, José Nativi-Nicolau, Frederick L. Ruberg	0
5	Prognostic Value of Left Ventricular 18F-Florbetapir Uptake in Systemic Light-Chain Amyloidosis 2024 ·JACC. Cardiovascular imaging ·Olivier Clerc, (unknown), Sarah Cuddy, Giada Bianchi, (unknown), Dominik C. Benz, Matthew Robertson, Marie Foley Kijewski, Michael Jerosch‐Herold, Raymond Y. Kwong, Frederick L. Ruberg, Ronglih Liao, Marcelo F. Di Carli, Rodney H. Falk, Sharmila Dorbala	15
6	Cardiac Amyloidosis Due to Transthyretin Protein breakdown → 2024 ·JAMA ·Frederick L. Ruberg, Matthew J. Maurer	65
7	Clinical Penetrance of the Transthyretin V122I Variant in Older Black Patients With Heart Failure: The SCAN‐MP (Screening for Cardiac Amyloidosis With Nuclear Imaging in Minority Populations) Study 2023 ·Journal of the American Heart Association ·(unknown), (unknown), (unknown), (unknown), (unknown), Denise Fine, Stephen Helmke, (unknown), (unknown), Farbod Raiszadeh, Sergio Teruya, Elizabeth Cohn, Andrew J. Einstein, Edward J. Miller, Lawreen H. Connors, Matthew J. Maurer, Frederick L. Ruberg	17
8	Predictors of treatment response and survival outcomes in patients with advanced cardiac AL amyloidosis 2023 ·Blood Advances ·Joshua Gustine, Andrew Staron, Lisa Mendelson, (unknown), Deepa M. Gopal, Omar K. Siddiqi, Frederick L. Ruberg, Vaishali Sanchorawala	9
9	Scanner‐Independent MyoMapNet for Accelerated Cardiac MRI T₁ Mapping Across Vendors and Field Strengths 2023 ·Journal of Magnetic Resonance Imaging ·Amine Amyar, Ahmed S. Fahmy, Rui Guo, Kei Nakata, (unknown), Jennifer Rodriguez, (unknown), (unknown), Jiwon Kim, Robert M. Judd, Frederick L. Ruberg, Jonathan W. Weinsaft, Reza Nezafat	3
10	Optimal Echocardiographic Parameters to Improve the Diagnostic Yield of Tc-99m-Bone Avid Tracer Cardiac Scintigraphy for Transthyretin Cardiac Amyloidosis 2022 ·Circulation Cardiovascular Imaging ·Sarah Cuddy, (unknown), (unknown), (unknown), Sean Murphy, Camden Bay, (unknown), (unknown), Varsha Muralidhar, (unknown), Jacqueline Vuong, (unknown), Matthew J. Maurer, Frederick L. Ruberg, Rodney H. Falk, Sharmila Dorbala	13
11	Outcomes by Cardiac Stage in Patients With Newly Diagnosed AL Amyloidosis 2022 ·JACC CardioOncology ·Monique C. Minnema, Angela Dispenzieri, Giampaolo Merlini, Raymond L. Comenzo, Efstathios Kastritis, Ashutosh Wechalekar, Martha Grogan, Ronald Witteles, Frederick L. Ruberg, Matthew J. Maurer, NamPhuong Tran, Xiang Qin, Sandra Y. Vasey, Brendan M. Weiss, Jessica Vermeulen, Arnaud Jaccard	12
12	Utilization of cardiovascular magnetic resonance (CMR) imaging for resumption of athletic activities following COVID-19 infection: an expert consensus document on behalf of the American Heart Association Council on Cardiovascular Radiology and Intervention (CVRI) Leadership and endorsed by the Society for Cardiovascular Magnetic Resonance (SCMR) 2022 ·Journal of Cardiovascular Magnetic Resonance ·Frederick L. Ruberg, Aaron L. Baggish, Allison G. Hays, Michael Jerosch‐Herold, Jiwon Kim, Karen Ordovás, Gautham P. Reddy, Chetan Shenoy, Jonathan W. Weinsaft, Pamela K. Woodard	1
13	Myocardial Composition in Light-Chain Cardiac Amyloidosis More Than 1 Year After Successful Therapy 2021 ·JACC. Cardiovascular imaging ·Sarah Cuddy, Michael Jerosch‐Herold, Rodney H. Falk, Marie Foley Kijewski, Vasvi Singh, Frederick L. Ruberg, Vaishali Sanchorawala, Heather Landau, Matthew Maurer, Andrew J. Yee, Giada Bianchi, Marcelo F. Di Carli, Ronglih Liao, Raymond Y. Kwong, Sharmila Dorbala	13
14	Improved Quantification of Cardiac Amyloid Burden in Systemic Light Chain Amyloidosis 2020 ·JACC. Cardiovascular imaging ·Sarah Cuddy, Paco E. Bravo, Rodney H. Falk, (unknown), Marie Foley Kijewski, Mi‐Ae Park, Frederick L. Ruberg, Vaishali Sanchorawala, Heather Landau, Andrew J. Yee, Giada Bianchi, Marcelo F. Di Carli, Su-Chun Cheng, Michael Jerosch‐Herold, Raymond Y. Kwong, Ronglih Liao, Sharmila Dorbala	53
15	Cardiac Scintigraphy With Technetium-99m-Labeled Bone-Seeking Tracers for Suspected Amyloidosis 2020 ·Journal of the American College of Cardiology ·Mazen Hanna, Frederick L. Ruberg, Matthew J. Maurer, Angela Dispenzieri, Sharmila Dorbala, Rodney H. Falk, James E. Hoffman, Wael A. Jaber, Prem Soman, Ronald Witteles, Martha Grogan	143
16	Abstract 13123: Diflunisal is Associated With Improved Mortality in Patients With Wild-Type ATTR Cardiac Amyloidosis: The BU Amyloidosis Center Experience 2019 ·Circulation ·(unknown), John L. Berk, Lawreen H. Connors, Gheorghe Doros, Deepa M. Gopal, (unknown), (unknown), (unknown), Frederick L. Ruberg, Omar K. Siddiqi	2
17	Transthyretin Amyloid Cardiomyopathy breakdown → 2019 ·Journal of the American College of Cardiology ·Frederick L. Ruberg, Martha Grogan, Mazen Hanna, Jeffery W. Kelly, Mathew S. Maurer	633
18	Transthyretin V122I (pV142I)* cardiac amyloidosis: an age-dependent autosomal dominant cardiomyopathy too common to be overlooked as a cause of significant heart disease in elderly African Americans 2017 ·Genetics in Medicine ·Joel N. Buxbaum, Frederick L. Ruberg	110
19	Abstract 12603: Global T1 Mapping and Late Gadolinium Enhancement Cardiac MR in Myocardial Fibrosis Compared with Amyloid Cardiomyopathy 2012 ·Circulation ·(unknown), Chimela Ohaji, Michael P. LaValley, Yansong Zhao, John L. Berk, Vaishali Sanchorawala, Wilson S. Colucci, David C. Seldin, Frederick L. Ruberg	1
20	Newer cardiac imaging techniques: multidetector CT angiography. 2006 ·PubMed ·Ravin Davidoff, Frederick L. Ruberg	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact